The good news? In the vast majority of cases, it is treatable once the underlying cause is identified.

What Is Dyspareunia?

Dyspareunia refers to persistent or recurrent pain in the genital area or pelvis that occurs before, during, or after sexual intercourse. The pain can range from mild discomfort to sharp, burning, or stabbing sensations, and it can be either superficial (felt at the vaginal entrance) or deep (felt in the lower abdomen or pelvis during penetration).

Common Causes of Painful Intercourse

1. Vaginal Dryness and Hormonal Changes

One of the most frequent culprits is insufficient vaginal lubrication. This is commonly caused by declining estrogen levels, something that naturally occurs during menopause, postpartum recovery, and even while using certain hormonal birth control pills. When vaginal tissue becomes thin and dry, friction during intercourse causes burning, rawness, and pain.

A 2019 study in Menopause: The Journal of The Menopause Society found that genitourinary syndrome of menopause (GSM), a condition involving vaginal dryness and tissue thinning affects up to 45% of postmenopausal women, yet fewer than 25% seek treatment.

2. Endometriosis

Endometriosis occurs when tissue similar to the uterine lining grows outside the uterus, on the ovaries, fallopian tubes, or surrounding pelvic structures. This misdirected tissue responds to hormonal cycles just like normal uterine tissue, causing inflammation, scarring, and significant pain. Deep pain during intercourse is one of the hallmark symptoms.

Research published in Human Reproduction estimates that endometriosis affects roughly 10% of women of reproductive age globally, though many go undiagnosed for years.

3. Vaginismus

Vaginismus is an involuntary tightening or spasm of the muscles surrounding the vaginal opening, making penetration painful or sometimes impossible. It can be triggered by anxiety, past trauma, fear of pain, or have no clear psychological cause at all. According to a review in the Journal of Sexual Medicine, vaginismus is significantly underdiagnosed and undertreated, despite being highly responsive to pelvic floor therapy.

4. Infections

Vaginal infections are a common and often overlooked cause of pain during sex. These include:

• Bacterial vaginosis (BV) — an imbalance of vaginal bacteria causing irritation and discharge
• Yeast infections — causing itching, burning, and swelling
• Sexually transmitted infections (STIs) — such as chlamydia, gonorrhea, herpes, or trichomoniasis, which can cause inflammation and discomfort

Any active infection in the vaginal or pelvic area can make intercourse painful and should be treated promptly.

5. Vulvodynia

Vulvodynia is chronic vulvar pain lasting three months or more with no identifiable cause. It often manifests as burning, stinging, or rawness, particularly during touch or penetration. According to the National Vulvodynia Association, up to 16% of women will experience vulvodynia symptoms at some point in their lives, making it far more common than most people realize.

6. Pelvic Inflammatory Disease (PID)

PID is an infection of the female reproductive organs typically the uterus, fallopian tubes, and ovaries, most often caused by untreated STIs. It causes significant pelvic tenderness, and intercourse can trigger or worsen this deep, aching pain. Left untreated, PID can lead to scarring and fertility problems.

7. Uterine Fibroids and Ovarian Cysts

Fibroids are noncancerous growths in or on the uterus, while ovarian cysts are fluid-filled sacs on the ovaries. Depending on their size and location, both can press on surrounding structures and cause deep pelvic pressure or pain especially during sex in certain positions.

8. Pelvic Floor Dysfunction

Beyond vaginismus, general pelvic floor dysfunction including muscles that are too tight, too weak, or uncoordinated can cause or contribute to painful intercourse. A 2021 review in Physical Therapy emphasized that pelvic floor physical therapy is an evidence-based, highly effective intervention for many forms of dyspareunia.

When Should You See a Doctor?

You should schedule an appointment if:

• Pain during or after sex happens consistently
• You notice unusual discharge, bleeding after sex, or an unpleasant odor
• You experience pelvic pain outside of sexual activity
• Pain has been worsening over time
• You’ve recently gone through menopause, had a baby, or started new hormonal contraception

Do not wait and hope it resolves on its own. Pain during intercourse is your body signaling that something needs attention.

How Is It Treated?

Treatment is entirely dependent on the cause. Your doctor may recommend:

• Topical estrogen or vaginal moisturizers for dryness and atrophy
• Antibiotics or antifungal medication for infections
• Pelvic floor physical therapy for vaginismus or muscle dysfunction
• Hormonal therapy for endometriosis or menopause-related symptoms
• Minimally invasive surgery for fibroids, cysts, or severe endometriosis
• Counseling or sex therapy when psychological factors are contributing

The key is getting the right diagnosis first. A thorough gynecological evaluation including a pelvic exam, relevant lab work, and a full medical history is the essential first step.

You deserve Intimacy free from pain.

Schedule your women’s health appointment with IVANA MD in Missouri City, TX.

Compassionate, expert care for all aspects of women’s health — including painful intercourse, hormonal concerns, and gynecological conditions.

Call: 346-585-4077 

Address: 4220 Cartwright Road, Suite 201, Missouri City, Texas 77459

Your health, your comfort, and your quality of life matter. Call us today.

This blog is for informational purposes only and does not constitute medical advice. Please consult a qualified healthcare provider for diagnosis and treatment.

References

1. American College of Obstetricians and Gynecologists (ACOG). (2020). When sex is painful. https://www.acog.org/womens-health/faqs/when-sex-is-painful
2. World Health Organization (WHO). (2023). Endometriosis. https://www.who.int/news-room/fact-sheets/detail/endometriosis
3. The Journal of Sexual Medicine. (2022). Vaginismus: An overview. https://academic.oup.com/jsm/article/19/Supplement_2/S228/7013310
4. National Vulvodynia Association (NVA). (2023). What is vulvodynia? nva.org

The post Causes of Pain During Intercourse (Dyspareunia): What Every Woman Should Know appeared first on IvanaMd.

The General Rule

According to the Merck Manual Professional Edition, any pelvic pain that is new, starts abruptly, or intensifies rapidly over a short period of time should be evaluated as soon as possible. Severe symptoms typically indicate an infection, inflammation, or obstruction that requires immediate medical attention to prevent serious complications, up to and including death.

Emergency Red Flags: When to Go to the ER Now

Do not wait for an office appointment if you are experiencing:

• Sudden, severe pelvic pain that comes on quickly and intensifies within minutes or hours
• Pelvic pain with fever above 101 degrees Fahrenheit, which may signal a life-threatening infection
• Pelvic pain with vaginal bleeding if you are pregnant or might be pregnant
• Sharp one-sided pelvic pain with dizziness, weakness, or fainting
• Pelvic pain accompanied by nausea, vomiting, and sweating
• Abdominal rigidity or guarding (the belly feels hard and is very tender to the touch)
• Severe pain in the lower right abdomen, especially with vomiting and fever, which may indicate appendicitis

Ectopic Pregnancy: A True Life-Threatening Emergency

An ectopic pregnancy occurs when a fertilized egg implants outside the uterus, most commonly in one of the fallopian tubes. As the embryo grows, it stretches and can rupture the tube, causing sudden and severe internal bleeding. This is one of the most dangerous gynecological emergencies.

Symptoms include sharp pelvic or abdominal pain (often one-sided), vaginal bleeding, dizziness, weakness, and in cases of rupture, sudden worsening pain with shoulder pain (from blood irritating the diaphragm). If you have a positive pregnancy test or believe you might be pregnant and experience any of these symptoms, call 911 or go to the emergency room immediately. Do not drive yourself if you are feeling faint.

Ovarian Torsion: A Surgical Emergency

Ovarian torsion occurs when an ovary rotates on its supporting ligaments, cutting off its blood supply. Without prompt surgical intervention, the ovary can suffer permanent damage or die. It accounts for approximately 3 percent of all gynecological surgical emergencies.

Symptoms typically include sudden onset of severe pelvic pain (usually one-sided), nausea, vomiting, and sometimes a low-grade fever. The pain may be constant or come in waves. Torsion can occur at any age, including in children, and can happen even when blood flow appears normal on Doppler ultrasound, which is why clinical presentation matters.

Ruptured Ovarian Cyst

Most ovarian cysts are harmless and resolve on their own without any intervention. But when a cyst ruptures and bleeds significantly, the result can be severe pelvic pain, dizziness from blood loss, and in some cases, hemodynamic instability. A ruptured cyst that causes significant internal bleeding requires emergency evaluation. Symptoms include sudden sharp pelvic pain (often one-sided), bloating, nausea, and sometimes lightheadedness.

Severe Acute Pelvic Inflammatory Disease

Pelvic inflammatory disease (PID) is a bacterial infection of the female reproductive organs, typically caused by an untreated sexually transmitted infection such as chlamydia or gonorrhea. When mild, PID can be treated with oral antibiotics on an outpatient basis. When severe, it can lead to tubo-ovarian abscess (a dangerous pocket of infection), sepsis, and permanent damage to the fallopian tubes.

Warning signs of severe PID include high fever, severe lower abdominal and pelvic pain, abnormal discharge, nausea, and significant tenderness on pelvic exam. Women in this state typically require hospital admission for IV antibiotics.

When Pelvic Pain Is Serious but Not an Emergency

Not all concerning pelvic pain is an emergency, but that does not mean it should be ignored. Chronic pelvic pain persisting for more than six months, progressive worsening of menstrual pain over several cycles, pain during intercourse, or pain that significantly disrupts your daily life all warrant prompt evaluation with your gynecologist, even if you are not in acute distress.

If you are uncertain whether your pain is urgent, err on the side of caution and contact a provider. The team at Ivana MD serves women across Sugar Land, Missouri City, Stafford, Richmond, League City, Houston, and Fort Bend County, and we are here to help you get the answers and care you need. When it comes to pelvic pain, your instincts matter. Trust them.

The post When Is Pelvic Pain an Emergency? appeared first on IvanaMd.

What Is Infertility?

Infertility is defined as the inability to conceive after 12 months of regular, unprotected intercourse  or 6 months if you are 35 or older. It is a medical condition, not a personal failure. According to the American Society for Reproductive Medicine (ASRM), a complete fertility evaluation identifies a probable cause in approximately 85–90% of couples, making early evaluation one of the most important steps you can take.

Step 1: Medical History & Physical Exam

Your OB-GYN begins with a thorough review of your menstrual cycle history, prior pregnancies, sexual health history, medications, and lifestyle factors such as weight, stress, and smoking. A pelvic exam checks for structural abnormalities. This conversation alone can uncover critical clues about what may be affecting your fertility.

Step 2: Hormone Blood Tests

Hormonal imbalances are among the most common causes of female infertility. Your doctor will likely order:

• FSH & LH — follicle-stimulating and luteinizing hormones that regulate ovulation
• AMH (Anti-Müllerian Hormone) — the most reliable marker of ovarian reserve. Research published in the Journal of Clinical Endocrinology & Metabolism confirms AMH is one of the strongest predictors of fertility treatment response.
• Estradiol & Progesterone — to assess ovulatory function
• TSH & Prolactin — thyroid dysfunction and elevated prolactin are often overlooked causes of irregular cycles and infertility

Step 3: Ovarian Reserve Testing & Ultrasound

A transvaginal ultrasound allows your OB-GYN to count antral follicles (AFC) — small follicles that indicate your egg supply. This painless imaging also detects fibroids, ovarian cysts, and signs of endometriosis or polycystic ovarian syndrome (PCOS), all of which are leading causes of female infertility.

Step 4: Hysterosalpingography (HSG)

An HSG is an X-ray procedure that evaluates whether your fallopian tubes are open and your uterine cavity is normal. Blocked fallopian tubes prevent sperm from reaching the egg and are a significant infertility factor. Studies show HSG has a diagnostic accuracy of over 85% for tubal obstruction.

Step 5: Additional Testing When Needed

• Laparoscopy — minimally invasive surgery to identify endometriosis or pelvic adhesions
• Endometrial biopsy — evaluates the health of the uterine lining
• Genetic testing — recommended in cases of recurrent pregnancy loss

Common Causes of Female Infertility

• Ovulatory disorders (including PCOS) — the most common cause, accounting for up to 40% of female infertility cases
• Blocked or damaged fallopian tubes — often caused by prior infection, endometriosis, or surgery
• Uterine abnormalities — fibroids, polyps, or structural issues affecting implantation
• Diminished ovarian reserve — fewer or lower-quality eggs, detected via AMH and AFC testing
• Unexplained infertility — diagnosed in approximately 10–15% of couples after a full evaluation

When Should You See an OB-GYN?

Do not wait until something feels seriously wrong. Seek an evaluation if:

• You are under 35 and have been trying to conceive for 12 months
• You are 35 or older and have been trying for 6 months
• You have irregular or absent periods
• You have a known condition such as PCOS, endometriosis, or fibroids
• You have experienced two or more miscarriages

Early evaluation leads to earlier answers and more options.

Schedule Your Women’s Health Appointment with IVANA MD

If you have questions about your fertility or are ready for an evaluation, our experienced women’s health team in Missouri City, TX is here for you.

Call: 346-585-4077

4220 Cartwright Road, Suite 201, Missouri City, Texas 77459

This blog is for educational purposes only and does not constitute medical advice. Always consult a qualified women’s health provider for evaluation and treatment.

The post How OB-GYNs Diagnose Infertility: What Every Woman Should Know appeared first on IvanaMd.

If you have noticed spotting during what you think might be menopause, you are not alone and the answer to whether it is “normal” depends on one critical distinction: are you in perimenopause, or have you already reached menopause?

That single distinction changes everything about how spotting should be interpreted and whether it requires urgent attention.

Perimenopause Spotting: Often Normal, But Still Worth Monitoring

Perimenopause — the transition phase leading up to menopause, which can last 4 to 10 years is characterized by fluctuating hormones, irregular ovulation, and unpredictable menstrual patterns. During this phase, spotting and irregular bleeding are extremely common.

According to a landmark study published in Obstetrics & Gynecology (2006) by Harlow et al., over 90% of women experience irregular bleeding during the perimenopausal transition, including spotting between periods, heavier-than-usual flows, and cycles that vary widely in length and timing.

Why it happens: As estrogen and progesterone levels fluctuate erratically, the uterine lining (endometrium) builds up and sheds unpredictably causing spotting that may appear between periods or instead of a regular period.

Perimenopausal spotting that is considered within the range of normal includes:

• Light spotting between periods that resolves on its own
• Shorter or longer cycles than you are used to
• One or two heavier-than-normal periods mixed with lighter ones
• Occasional mid-cycle spotting linked to irregular ovulation

Perimenopausal spotting that warrants prompt evaluation:

• Bleeding that is extremely heavy (soaking a pad every hour for 2+ hours)
• Spotting or bleeding every day without pause
• Bleeding after intercourse consistently
• Spotting that has been going on for weeks without stopping

A study published in BJOG (2010) found that while irregular bleeding is expected during perimenopause, heavy or prolonged bleeding significantly increased the likelihood of underlying endometrial pathology, underscoring the importance of evaluation when bleeding is outside the “expected irregular” range. 

Postmenopausal Bleeding: Never Ignore It

Here is where the conversation shifts completely.

Postmenopause is defined as 12 or more consecutive months without a menstrual period. Once you have reached this milestone, any vaginal bleeding no matter how light is not normal and requires prompt medical evaluation.

This includes:

• A few drops of spotting
• Pink or brownish discharge
• A single episode of light bleeding that seems to stop on its own

Research published in the New England Journal of Medicine (2001) by Clark et al. found that postmenopausal bleeding is the presenting symptom in approximately 90% of women with endometrial (uterine) cancer making it one of the most important early warning signs in gynecologic health. However, this is equally important as the majority of women with postmenopausal bleeding do NOT have cancer. Studies show that endometrial cancer accounts for only 5–10% of postmenopausal bleeding cases. The other 90–95% have benign, treatable causes.

The most common causes of postmenopausal bleeding include:

Endometrial atrophy (thinning of the uterine lining) — the most common cause overall, accounting for up to 60–80% of cases. As estrogen declines, the endometrium becomes thin and fragile, causing minor bleeding without any underlying disease.

Vaginal atrophy (Genitourinary Syndrome of Menopause / GSM) — declining estrogen causes thinning and fragility of vaginal and cervical tissues, which can bleed with minimal friction or pressure. A study in Menopause (2014) found GSM affected nearly 50% of postmenopausal women and was a frequent source of postmenopausal bleeding.

Endometrial polyps — benign overgrowths of the uterine lining that are highly responsive to a hormonal environment, making them common in women on hormone therapy or those with estrogen excess.

Uterine fibroids — while fibroids often shrink after menopause, some remain active, particularly in women on hormone therapy.

Endometrial hyperplasia — a proliferation of the uterine lining caused by unopposed estrogen exposure; a precancerous condition that is highly treatable when caught early.

Endometrial cancer — the diagnosis that must always be excluded. The good news: when detected early (as postmenopausal bleeding typically allows), endometrial cancer has a 5-year survival rate exceeding 95%, according to the American Cancer Society (2023).

Cervical pathology — cervical polyps, cervicitis, or, rarely, cervical cancer.

What Happens When You See Your Doctor for Postmenopausal Bleeding?

Your provider will take a thorough history and will likely recommend:

Transvaginal ultrasound (TVUS) — the first-line diagnostic test. It measures the thickness of the endometrial lining. A study published in The Lancet (1995) by Smith-Bindman et al. established that an endometrial thickness of 4 mm or less on TVUS had a very high negative predictive value for endometrial cancer — making ultrasound an essential, often reassuring initial step.

Endometrial biopsy — a quick, in-office procedure in which a small sample of the uterine lining is taken for pathological analysis. It is the most definitive method for diagnosing or excluding endometrial hyperplasia and cancer.

Sonohysterography or hysteroscopy — if polyps, fibroids, or other structural abnormalities are suspected, these procedures provide direct visualization of the uterine cavity.

Most causes of postmenopausal bleeding once cancer has been excluded are highly treatable. Atrophy responds excellently to local vaginal estrogen. Polyps can be removed hysteroscopically. Hyperplasia is treated with progestogen therapy or surgical intervention depending on severity.

Spotting on Hormone Therapy: A Special Note

Women who have recently started hormone therapy (HT)  particularly combined estrogen-progestogen therapy frequently experience breakthrough bleeding or spotting in the first 3 to 6 months of treatment. This is a recognized and expected adjustment period as the body adapts to exogenous hormones.

A study published in Fertility and Sterility (2009) confirmed that irregular bleeding in the first 6 months of continuous combined HT was extremely common and did not indicate pathology in the majority of cases.

However, any bleeding that:

• Occurs after 6 months of stable HT use
• Is heavier than a normal period
• Returns after a period of no bleeding

…requires evaluation to exclude endometrial pathology, regardless of HT use.

The Bottom Line: Know Your Stage, Know Your Risk

Spotting during the menopausal transition is a signal your body is sending. Most of the time it is benign. But because it can occasionally reflect something serious and because the serious things are so treatable when caught early it always deserves a conversation with your provider, not a wait-and-see approach. 

Frequently Asked Questions

Can stress cause spotting during menopause? Yes, psychological and physical stress can disrupt the hormonal axis, affecting ovulation and causing breakthrough spotting during perimenopause. However, stress alone does not explain postmenopausal bleeding, which always requires evaluation.

Is brown spotting during menopause serious? Brown spotting (oxidized blood) is still bleeding and carries the same significance as red spotting. In postmenopausal women, brown spotting or discharge should be evaluated just as promptly as red bleeding.

How quickly should I be seen for postmenopausal bleeding? Within 1–2 weeks is generally recommended. While the cause is most often benign, prompt evaluation ensures that any significant pathology is identified and treated at the earliest possible stage.

Noticed spotting and not sure what it means? Do not wait and wonder. At IVANA MD in Missouri City, TX, our experienced women’s health team provides thorough, compassionate evaluations for all stages of the menopausal transition including personalized assessment of abnormal bleeding.

Your health is worth the conversation.

Schedule Your Women’s Health Appointment with IVANA MD

Call: 346-585-4077

4220 Cartwright Road, Suite 201, Missouri City, Texas 77459

This blog is for educational purposes only and does not constitute medical advice. Always consult a qualified women’s health provider for evaluation of any bleeding or spotting during the menopausal transition.

References

1. Harlow, S. D., & Ephross, S. A. (1995). Epidemiology of menstruation and its relevance to women’s health. Epidemiologic Reviews, 17(2), 265–286. https://doi.org/10.1093/oxfordjournals.epirev.a036193
2. Clark, T. J., Mann, C. H., Shah, N., Khan, K. S., Song, F., & Gupta, J. K. (2002). Accuracy of outpatient endometrial biopsy in the diagnosis of endometrial cancer: a systematic quantitative review. BJOG, 109(3), 313–321. https://doi.org/10.1111/j.1471-0528.2002.01088.x
3. Smith-Bindman, R., Kerlikowske, K., Feldstein, V. A., Subak, L., Scheidler, J., Segal, M., … & Grady, D. (1998). Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities. JAMA, 280(17), 1510–1517. https://doi.org/10.1001/jama.280.17.1510
4. Nappi, R. E., & Kokot-Kierepa, M. (2012). Vaginal Health: Insights, Views & Attitudes (VIVA) results from an international survey. Climacteric, 15(1), 36–44. https://doi.org/10.3109/13697137.2011.647840
5. American Cancer Society. (2023). Endometrial Cancer Survival Rates. Retrieved from https://www.cancer.org/cancer/endometrial-cancer/detection-diagnosis-staging/survival-rates.html
6. Goldstein, S. R. (2010). The role of transvaginal ultrasound or endometrial biopsy in the evaluation of the menopausal endometrium. American Journal of Obstetrics and Gynecology, 202(3), 259–265. https://doi.org/10.1016/j.ajog.2009.07.038

The post Is Spotting During Menopause Normal?  appeared first on IvanaMd.

Here is what actually works, backed by science and explained plainly.

The Lifestyle Foundation (Start Here, No Matter What)

These are proven interventions that every woman should build into her routine.

Eat like you live near the Mediterranean Vegetables, fruits, whole grains, legumes, olive oil, and fatty fish make up a dietary pattern consistently linked to fewer and less severe hot flashes, better sleep, and lower inflammation. Two to three daily servings of soy foods (edamame, tofu, tempeh) also help research across 62 trials found they reduce hot flash frequency by around 20–25%. Not as dramatic as medication, but real.

Practical tips: add ground flaxseed daily, reduce alcohol (it worsens hot flashes and disrupts sleep), and cut afternoon caffeine.

Move your body — consistently Exercise may be the single most powerful multi-symptom tool available. It reduces hot flash severity, protects bone density, improves mood, sharpens mental clarity, and helps with the weight changes many women experience. Aim for 150+ minutes of moderate cardio weekly, plus two to three strength training sessions. Even 30 minutes of brisk walking daily makes a meaningful difference.

Protecting your sleep Sleep disruption makes every other symptom worse. Keep your bedroom cool (60–67°F), avoid alcohol within three hours of bedtime, cut screens an hour before sleep, and consider Cognitive Behavioral Therapy for Insomnia (CBT-I) research consistently shows it outperforms sleep medications for long-term results.

Mind-Body Approaches: Surprisingly Powerful

CBT for menopause is one of the most well-studied non-pharmaceutical options available. A landmark Lancet trial found it significantly reduced hot flash distress, sleep disruption, and mood difficulties with effects lasting at least six months. It does not stop hot flashes from happening, but it dramatically reduces how much they affect your life. Usually just 4–6 sessions.

Paced breathing (slow, diaphragmatic breaths at about six per minute) has been shown in clinical trials to cut hot flash frequency by roughly 50%. It costs nothing and can be done anywhere.

Yoga and mindfulness (MBSR) both show meaningful benefits for sleep, stress, anxiety, and overall quality of life in menopausal women.

Supplements: What the Evidence Actually Shows

The supplement market is enormous and largely oversells its results. Here is what the research says honestly:

Worth considering:

• Soy isoflavones — modest but real reduction in hot flashes (~20–25%), best from whole foods
• Magnesium glycinate (300–400 mg) — supports sleep and bone health; may reduce hot flash frequency
• Melatonin (0.5–3 mg) — helps with sleep onset in perimenopausal women
• Black cohosh — evidence is inconsistent; may help some women mildly; safe for most (avoid with liver conditions)

Non-Hormonal Prescription Medications

For women who need more relief than lifestyle and supplements provide or who can not use hormones,  several prescription options have solid evidence:

Fezolinetant (Veozah) — FDA-approved in 2023 specifically for hot flashes. Reduces frequency by ~59% and severity by ~62%. No estrogenic activity, making it appropriate for breast cancer survivors too.

SSRIs/SNRIs — Originally antidepressants, these also reduce hot flashes meaningfully. Venlafaxine and escitalopram are the most used. Bonus: they also help with the mood changes many women experience during this transition. (Note: paroxetine should not be used by women on tamoxifen.)

Gabapentin — Particularly effective for nighttime hot flashes and sleep disruption. Often taken as a single bedtime dose.

Local vaginal estrogen — Minimal systemic absorption, appropriate even for many women who can not use systemic hormones. Highly effective for vaginal dryness and discomfort. Available as tablets, cream, or a ring.

Hormone Therapy: The Most Effective Option Available

For moderate-to-severe symptoms, the evidence is clear: hormone therapy (HT) outperforms every other approach. Hot flash reduction with HT reaches 75–90%, compared to 20–25% with phytoestrogens or 45–60% with fezolinetant.

Current guidance from The Menopause Society (2022) confirms that for healthy women under 60 and within 10 years of menopause onset with no contraindications, the benefit-risk ratio is favorable.

Modern HT has evolved significantly. Transdermal estradiol (patch, gel, or spray) is now preferred over oral estrogen,  it carries a lower clot risk and produces more stable hormone levels. Micronized progesterone (for women with a uterus) is better tolerated than older synthetic versions and even supports sleep.

HT is not right for everyone but for the right candidate, it is  the most effective tool on the table.

The Bottom Line

The smartest approach is not “natural vs. medical”  it is both, combined thoughtfully. Research shows women who pair hormone therapy with exercise and a Mediterranean-style diet report better outcomes than those using any single approach alone.

Start with the lifestyle foundation. Add supplements if appropriate. If you need more, non-hormonal prescriptions are a real, evidence-backed option. And if your symptoms are significantly disrupting your life and you’re a good candidate  do not let outdated fears keep you from the most effective treatment available.

Talk to a provider who will take your symptoms seriously and build a plan that fits your life. That is what you deserve.

Schedule Your Women’s Health Appointment with IVANA MD

Call: 346-585-4077

4220 Cartwright Road, Suite 201, Missouri City, Texas 77459

This blog is intended for educational and informational purposes only and does not constitute medical advice. Always consult a qualified women’s health provider before starting, changing, or stopping any menopause treatment  including supplements, prescription medications, or hormone therapy.

References

1. Franco OH, Chowdhury R, Troup J, et al. Use of plant-based therapies and menopausal symptoms: a systematic review and meta-analysis. JAMA. 2016;315(23):2554–2563.
2. Levis S, Griebeler ML. The role of soy foods in the treatment of menopausal symptoms. Journal of Nutrition. 2010;140(12):2318S–2321S.
3. Barnard ND, Kahleova H, Holtz DN, et al. A dietary intervention for vasomotor symptoms of menopause: a randomized, controlled trial. Menopause. 2023;30(1):80–87.

4. Trichopoulou A, Bamia C, Trichopoulos D. Anatomy of health effects of Mediterranean diet: Greek EPIC prospective cohort study. BMJ. 2009;338:b2337. 
5. Kemmler W, Engelke K, von Stengel S, et al. Long-term exercise and bone mineral density changes in postmenopausal women. Journal of Bone and Mineral Research. 2010;25(1):14–23.

5. Zheng G, Qiu P, Xia R, et al. Effect of aerobic exercise on inflammatory markers in healthy middle-aged and older adults. Frontiers in Aging Neuroscience. 2019;11:98.
6. Kemmler W, Häberle L, von Stengel S. Effects of exercise on fracture reduction in older adults: a systematic review and meta-analysis. Osteoporosis International. 2013;24(7):1937–1950.

8. Ayers B, Smith M, Hellier J, Mann E, Hunter MS. Effectiveness of group and self-help cognitive behavior therapy in reducing problematic menopausal hot flushes and night sweats (MENOS 2). Menopause. 2012;19(7):749–759.
9. Lethaby A, Roberts H, Gulasekharam V, Sherburn M. Phytoestrogens for menopausal vasomotor symptoms. Cochrane Database of Systematic Reviews. 2019.
10. Freedman RR, Woodward S. Behavioral treatment of menopausal hot flushes: evaluation by ambulatory monitoring. American Journal of Obstetrics and Gynecology. 1992;167(2):436–439.
11. Lee MS, Kim JI, Ha JY, Boddy K, Ernst E. Yoga for menopausal symptoms: a systematic review. Menopause. 2009;16(3):602–608.

12. Leach MJ, Moore V. Black cohosh (Cimicifuga spp.) for menopausal symptoms. Cochrane Database of Systematic Reviews. 2012;(9):CD007244.
13. Newton KM, Reed SD, LaCroix AZ, et al. Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo: a randomized trial. Annals of Internal Medicine. 2006;145(12):869–879.
14. Park H, Parker GL, Boardman CH, Morris MM, Smith TJ. A pilot phase II trial of magnesium supplements to reduce menopausal hot flashes in breast cancer patients. Supportive Care in Cancer. 2011;19(6):859–863.
15. Aso T, Uchiyama S, Matsumura Y, et al. A natural S-equol supplement alleviates hot flushes and other menopausal symptoms in equol nonproducing postmenopausal Japanese women. Journal of Women’s Health. 2012;21(1):92–100.

16. Johnson KA, Martin N, Nappi RE, et al. Efficacy and safety of fezolinetant in moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1). Menopause. 2023;30(3):243–256.
17. Simon JA, Portman DJ, Kaunitz AM, et al. Low-dose paroxetine 7.5 mg for menopausal vasomotor symptoms: two randomized controlled trials. Menopause. 2013;20(10):1027–1035.
18. Loprinzi CL, Kugler JW, Sloan JA, et al. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial. Lancet. 2000;356(9247):2059–2063.
19. Freeman EW, Guthrie KA, Caan B, et al. Efficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial. JAMA. 2011;305(3):267–274.
20. Guttuso T Jr, Kurlan R, McDermott MP, Kieburtz K. Gabapentin’s effects on hot flashes in postmenopausal women: a randomized controlled trial. Obstetrics and Gynecology. 2003;101(2):337–345.
21. Suckling J, Kennedy R, Lethaby A, Roberts H. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database of Systematic Reviews. 2006;(4):CD001500.
22. Bachmann G, Bouchard C, Hoppe D, et al. Efficacy and safety of ospemifene in postmenopausal women with moderate-to-severe vulvar and vaginal atrophy. Menopause. 2010;17(3):480–486.

23. Marjoribanks J, Farquhar C, Roberts H, Lethaby A, Lee J. Long-term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database of Systematic Reviews. 2017;(1):CD004143.
24. The Menopause Society. The 2022 hormone therapy position statement of The Menopause Society. Menopause. 2022;29(7):767–794.
25. Fournier A, Berrino F, Clavel-Chapelon F. Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Breast Cancer Research and Treatment. 2008;107(1):103–111.
26. Shifren JL, Gass ML. The North American Menopause Society recommendations for clinical care of midlife women. Menopause. 2014;21(10):1038–1062.

The post Managing Menopause appeared first on IvanaMd.